| |
| |
|
| Insider
Information: |
Brown Bob |
| Relationship: |
Chief Scientific Ofr.,... |
| City: |
Watertown |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Dicerna Pharmaceuticals Inc |
DRNA |
Chief Scientific Ofr.,... |
2021-12-28 |
0 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Scientific Ofr., EVP R&D |
• – – |
2021-12-28 |
4 |
D |
$38.25 |
$90,538 |
D/D |
(2,367) |
0 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Scientific Ofr., EVP R&D |
• – – |
2021-12-15 |
4 |
D |
$38.05 |
$63,734 |
D/D |
(1,675) |
2,367 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Scientific Ofr., EVP R&D |
• – – |
2021-12-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,775 |
4,042 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Scientific Ofr., EVP R&D |
• – – |
2021-09-17 |
4 |
AS |
$21.06 |
$447,517 |
D/D |
(21,250) |
267 |
0 |
% |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Scientific Ofr., EVP R&D |
• – – |
2021-08-02 |
4 |
AS |
$37.38 |
$310,678 |
D/D |
(8,312) |
21,517 |
0 |
% |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Scientific Ofr., EVP R&D |
• – – |
2021-08-02 |
4 |
OE |
$3.42 |
$28,427 |
D/D |
8,312 |
29,829 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Scientific Ofr., EVP R&D |
• – – |
2021-07-01 |
4 |
OE |
$3.42 |
$28,427 |
D/D |
8,312 |
29,829 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Scientific Ofr., EVP R&D |
• – – |
2021-07-01 |
4 |
AS |
$37.30 |
$310,641 |
D/D |
(8,312) |
21,517 |
0 |
% |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Scientific Ofr., EVP R&D |
• – – |
2021-06-11 |
4 |
AS |
$34.00 |
$340,000 |
D/D |
(10,000) |
21,517 |
0 |
% |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Scientific Ofr., EVP R&D |
• – – |
2021-06-11 |
4 |
OE |
$9.09 |
$90,900 |
D/D |
10,000 |
31,517 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Scientific Ofr., EVP R&D |
• – – |
2021-06-07 |
4 |
AS |
$33.00 |
$330,000 |
D/D |
(10,000) |
21,517 |
0 |
% |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Scientific Ofr., EVP R&D |
• – – |
2021-06-07 |
4 |
OE |
$9.09 |
$90,900 |
D/D |
10,000 |
31,517 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Scientific Ofr., EVP R&D |
• – – |
2021-06-01 |
4 |
AS |
$30.88 |
$257,078 |
D/D |
(8,312) |
21,517 |
0 |
% |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Scientific Ofr., EVP R&D |
• – – |
2021-06-01 |
4 |
OE |
$3.42 |
$28,427 |
D/D |
8,312 |
29,829 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Scientific Ofr., EVP R&D |
• – – |
2021-05-03 |
4 |
AS |
$30.16 |
$251,672 |
D/D |
(8,312) |
21,517 |
0 |
% |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Scientific Ofr., EVP R&D |
• – – |
2021-05-03 |
4 |
OE |
$3.42 |
$28,427 |
D/D |
8,312 |
29,829 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Scientific Ofr., EVP R&D |
• – – |
2021-04-30 |
4 |
AS |
$32.00 |
$320,000 |
D/D |
(10,000) |
21,517 |
0 |
% |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Scientific Ofr., EVP R&D |
• – – |
2021-04-30 |
4 |
OE |
$9.09 |
$90,900 |
D/D |
10,000 |
31,517 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Scientific Ofr., EVP R&D |
• – – |
2021-04-29 |
4 |
AS |
$31.00 |
$310,000 |
D/D |
(10,000) |
21,517 |
0 |
% |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Scientific Ofr., EVP R&D |
• – – |
2021-04-29 |
4 |
OE |
$9.09 |
$90,900 |
D/D |
10,000 |
31,517 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Scientific Ofr., EVP R&D |
• – – |
2021-03-01 |
4 |
AS |
$28.90 |
$240,701 |
D/D |
(8,312) |
21,517 |
0 |
% |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Scientific Ofr., EVP R&D |
• – – |
2021-03-01 |
4 |
OE |
$9.09 |
$75,556 |
D/D |
8,312 |
29,829 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Scientific Ofr., EVP R&D |
• – – |
2021-02-03 |
4 |
OE |
$9.09 |
$75,556 |
D/D |
8,312 |
29,829 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Scientific Ofr., EVP R&D |
• – – |
2021-02-03 |
4 |
AS |
$25.00 |
$207,800 |
D/D |
(8,312) |
21,517 |
0 |
% |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Chief Scientific Ofr., EVP R&D |
• – – |
2021-01-25 |
4 |
AS |
$25.00 |
$540,750 |
D/D |
(21,630) |
21,517 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
